Literature DB >> 9454896

Expression and synthesis of insulin-like growth factor-binding proteins in human glioma cell lines.

W Zumkeller1, D Müller, S Müller, C Günther, M Westphal.   

Abstract

We previously demonstrated the presence of insulin-like growth factors (IGFs) and IGF-receptors in human glioma cell lines derived from primary glioblastomas. The biological action of IGFs is modulated by specific IGF-binding proteins (IGFBP)-1 to -7. By means of polymerase chain reaction (PCR), we detected mRNA transcripts for IGFBP-1 in 42%, IGFBP-2 in 65%, IGFBP-3 in 97%, IGFBP-4 in 3%, IGFBP-5 in 74%, IGFBP-6 in 94% and IGFBP-7 in 87% of the glioma cell lines. The specificity of the PCR reaction was verified by direct sequencing of the PCR product. In addition, the content of the most prevalent IGFBP-3 was measured in conditioned medium from glioma cells by specific radioimmunoassay with levels ranging from < 1 to 620 ng/ml. Moreover, the presence of membrane-bound IGFBPs (44, 50 and 60 kDa) as well as IGF-II receptors was demonstrated by using 125I-labelled IGF-II as a ligand. In conclusion, IGFBPs may modulate the IGF-mediated effects in these cell lines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9454896     DOI: 10.3892/ijo.12.1.129

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  3 in total

Review 1.  The IGF/IGFBP system in CNS malignancy.

Authors:  W Zumkeller; M Westphal
Journal:  Mol Pathol       Date:  2001-08

2.  Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma.

Authors:  Zhenglan Zhong; Xiaoping Xu; Shiguo Han; Yongxiang Shao; Yong Yi
Journal:  J Healthc Eng       Date:  2022-07-04       Impact factor: 3.822

Review 3.  Insulin-like growth factor-binding protein-5 (IGFBP-5): a critical member of the IGF axis.

Authors:  James Beattie; Gordon J Allan; Jennifer D Lochrie; David J Flint
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.